Cargando…
PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer
While peroxisome proliferator-activated receptor δ (PPAR-δ) and its associated signaling pathways have been shown to play an important regulatory role in various malignant tumors, in breast cancer, its potential influence on immune infiltration and its ability to serve as a prognostic marker remains...
Autores principales: | Wang, Zonghan, Dong, Hao, Li, Wei, Han, Fujun, Zhao, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158510/ https://www.ncbi.nlm.nih.gov/pubmed/37151397 http://dx.doi.org/10.7150/jca.81430 |
Ejemplares similares
-
MCTS1 as a Novel Prognostic Biomarker and Its Correlation With Immune Infiltrates in Breast Cancer
por: Deng, Mei, et al.
Publicado: (2022) -
NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008) -
SIRT7 Is a Prognostic Biomarker Associated With Immune Infiltration in Luminal Breast Cancer
por: Huo, Qin, et al.
Publicado: (2020) -
Identification of Angiogenesis-Related Prognostic Biomarkers Associated With Immune Cell Infiltration in Breast Cancer
por: Tao, Dan, et al.
Publicado: (2022) -
MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer
por: Tao, Zuo, et al.
Publicado: (2020)